Double autologous peripheral blood stem cells transplant for 21 patients with lymphoblastic lymphoma

李佳丽; 刘耀; 文钦; 朱丽丹; 向茜茜; 高蕾; 高力; 张诚; 孔佩艳; 刘红; 陈幸华; 张曦

您当前的位置：

首页 >

文章列表页 >

Double autologous peripheral blood stem cells transplant for 21 patients with lymphoblastic lymphoma

更新时间：2026-01-09

- Double autologous peripheral blood stem cells transplant for 21 patients with lymphoblastic lymphoma
- Journal of Army Medical University Vol. 38, Issue 12, Pages: 1350-1355(2016)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R329.24;R617;R733.4
- Published：2016
- 稿件说明：
移动端阅览
李佳丽,刘耀,文钦,朱丽丹,向茜茜,高蕾,高力,张诚,孔佩艳,刘红,陈幸华,张曦.双次自体造血干细胞移植治疗T淋巴母细胞淋巴瘤21例的临床疗效观察[J].陆军军医大学学报(原第三军医大学学报),2016,38(12):1350-1355.

　Li Jiali,Liu Yao,Wen Qin,Zhu Lidan,Xiang Xixi,Gao Lei,Gao Li,Zhang Cheng,Kong Peiyan,Liu Hong,Chen Xinghua,Zhang Xi.Double autologous peripheral blood stem cells transplant for 21 patients with lymphoblastic lymphoma[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(12):1350-1355.
李佳丽,刘耀,文钦,朱丽丹,向茜茜,高蕾,高力,张诚,孔佩艳,刘红,陈幸华,张曦.双次自体造血干细胞移植治疗T淋巴母细胞淋巴瘤21例的临床疗效观察[J].陆军军医大学学报(原第三军医大学学报),2016,38(12):1350-1355. DOI：

　Li Jiali,Liu Yao,Wen Qin,Zhu Lidan,Xiang Xixi,Gao Lei,Gao Li,Zhang Cheng,Kong Peiyan,Liu Hong,Chen Xinghua,Zhang Xi.Double autologous peripheral blood stem cells transplant for 21 patients with lymphoblastic lymphoma[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(12):1350-1355. DOI：

摘要

目的探讨双次自体造血干细胞移植（autologous peripheral blood stem cell transplant，APSCT）治疗T淋巴母细胞淋巴瘤的临床疗效和安全性。方法收集2008年2月至2013年11月在我院血液病中心接受双次APSCT的T淋巴母细胞淋巴瘤患者共21例

中位年龄29岁。按照Ann Arbor标准，Ⅲ期5例，Ⅳ期16例，第1次移植前处于完全缓解（complete remission，CR）16例，部分缓解（partial remission，PR）为5例。第1次移植采用以环己亚硝脲＋依托泊苷＋阿糖胞苷＋环磷酰胺联合方案进行预处理，以上患者在第1次移植后4～6个月进行第2次造血干细胞移植，预处理方案为伊达比星＋阿糖胞苷＋环磷酰胺。结果 ①所有患者双次自体移植后造血功能均顺利重建。 ②中位随访24个月，复发3例，死亡4例（因复发死亡2例，疾病进展死亡1例，移植相关死亡1例），无病存活12例，4例疾病稳定，1例研究截止时疾病复发进展。3年预期无进展生存为68.9%，总生存率为73.6%。 ③预后相关因素中，患者的年龄、第1次移植后疾病状态是否CR影响患者的总生存期（overall survival，OS）和无进展生存期（progression-free survival，PFS），第1次移植前疾病状态是否CR影响患者的OS。结论双次APSCT治疗T淋巴母细胞淋巴瘤患者疗效确切

造血重建顺利

移植相关死亡率低，安全性好。

Abstract

Objective To evaluate the efficacy and safety of tandem autologous peripheral blood stem cell transplant (APSCT) for lymphoblastic lymphoma. Methods Clinic data of 21 patients (median age of 29) with lymphoblastic lymphoma undergoing double APSCT in our hospital from February 2008 to November 2013 were collected and analyzed in this study. By Ann Arbor staging system

they were classified into 5 cases at stage Ⅲ and 16 cases at stage Ⅳ. Before the first transplantation

16 cases achieved complete remission (CR) and 5 cases achieved partial remission (PR). Mobilization regimen was Mit+Vds+VP16+Dex+MTX combined with G-CSF 5 μg/(kg·d). The conditioning regimens for the tandem transplantation were CCNU+VP-16+Ara-c+CTX and IDA+Ara-c+CTX respectively. The interval of the tandem transplantation was 4 to 6 months. Results All patients obtained prompt and sustained hematopoietic reconstitution after the tandem transplants. But 3 cases relapsed

4 cases died (2 died of recurrence

1 of disease progression

and 1 of transplantation related mortality)

1 case relapsed and progressed

12 cases were still in disease-free survival

and 4 remained stable after median follow-up of 24 (2～81) months. The 3-year progression-free survival (PFS) was 68.9%

and overall survival (OS) was 72.6%. Multivariate analysis demonstrated that OS and PFS were significantly affected by the age and disease status after first transplantation. The factor influencing OS was CR status or not after first transplantation. Conclusion Tandem APSCT is safe and effective for lymphoblastic lymphoma

with well hematopoietic reconstitution and low transplant-related mortality.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR⁺/HER2^- early breast cancer patients

Immunosuppressive microenvironment of TGIF1-overexpressing gastric cancers and its clinical significance

Impact of molecular heterogeneity of NPM1 mutations on prognosis of acute myeloid leukemia: a clinical report of 86 cases

Association of 5-factor modified frailty index and controlling nutritional status score with overall survival in patients with unresectable hepatocellular carcinoma undergoing interventional therapy

Construction and validation of prediction model for cervical cancer recurrence based on systemic inflammation response index and clinicopathological parameters

Related Author

WANG Chengfang

ZHOU Yuqin

ZHANG Yanling

QI Xiaowei

ZHANG Yi

TONG Huyun

CHEN Xu

ZHANG Wenjie

Related Institution

Department of Breast and Thyroid Surgery， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Gastroenterology， Chongqing Hechuan District People’s Hospital

School of Medicine， Chongqing University

Chongqing Key Laboratory of Precision Prevention and Treatment for Digestive System Tumors， Department of Gastroenterology， Army Medical Center of PLA/Daping Hospital of Third Military Medical University

Department of Hematology, the First Hospital of Lanzhou University

⁰